Management of asthma in pregnancy

The Lancet

Volumn 379, Issue 9821, 2012, Pages

  Barnes, Neil ^a   Greening, Andrew ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b NHS LOTHIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; NITRIC OXIDE; GLUCOCORTICOID;

ASTHMA; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; LETTER; PREGNANCY; PRIORITY JOURNAL; BREATH ANALYSIS; FEMALE; NOTE; PREGNANCY COMPLICATION;

ASTHMA; BREATH TESTS; FEMALE; GLUCOCORTICOIDS; HUMANS; NITRIC OXIDE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84859059725     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60464-4     Document Type: Letter

References (3)

1. H Powell, VE Murphy, R Taylor et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial Lancet 378 2011 983 990
2. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention http://www.ginasthma.org/guidelines-gina-report-global-strategy- for-asthma.html (accessed March 7, 2012).
3. British Thoracic Society, Scottish Intercollegiate Guideline Network British Guidelines on the Management of Asthma Thorax 63 suppl 14 2008 1 121